CD274 and neoplasm: Meanwhile, IFNs upregulate the expression of PD-L1 in tumor cells, forming an immunosuppressive feedback loop, but at the same time providing a synergistic therapeutic target for radiotherapy combined with anti-PD-L1 immune checkpoint inhibitors.